Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-18-045786)

Filing Details

Accession Number:: 0001104659-18-045786
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-18 17:00:32
Reporting Period:: 2018-07-16

Accepted Time:: 2018-07-18 17:00:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1585608	Jaguar Health Inc.	JAGX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1588209	B. Jonathan Siegel	C/O Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco CA 94105		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-07-16	7,500	$1.36	9,732	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-07-17	2,232	$1.19	9,732	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

Securities held directly by JBS Healthcare Ventures LLC. Mr. Siegel, by virtue of his position as the sole member of JBS Healthcare Ventures LLC, may be deemed to beneficially own the securities held by JBS Healthcare Ventures LLC for purposes of Section 16.